These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 27123785)

  • 1. Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels.
    Dambrova M; Latkovskis G; Kuka J; Strele I; Konrade I; Grinberga S; Hartmane D; Pugovics O; Erglis A; Liepinsh E
    Exp Clin Endocrinol Diabetes; 2016 Apr; 124(4):251-6. PubMed ID: 27123785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary, anthropometric, and biochemical factors influencing plasma choline, carnitine, trimethylamine, and trimethylamine-N-oxide concentrations.
    Malinowska AM; Szwengiel A; Chmurzynska A
    Int J Food Sci Nutr; 2017 Jun; 68(4):488-495. PubMed ID: 27855528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship Between Trimethylamine-N-Oxide and Prevalent Cardiovascular Disease in a Multiethnic Population Living in Canada.
    Mente A; Chalcraft K; Ak H; Davis AD; Lonn E; Miller R; Potter MA; Yusuf S; Anand SS; McQueen MJ
    Can J Cardiol; 2015 Sep; 31(9):1189-94. PubMed ID: 26239008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE(-/-) transgenic mice expressing CETP.
    Collins HL; Drazul-Schrader D; Sulpizio AC; Koster PD; Williamson Y; Adelman SJ; Owen K; Sanli T; Bellamine A
    Atherosclerosis; 2016 Jan; 244():29-37. PubMed ID: 26584136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
    Mueller DM; Allenspach M; Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A
    Atherosclerosis; 2015 Dec; 243(2):638-44. PubMed ID: 26554714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of plasma trimethylamine N-oxide, choline, carnitine, and betaine with inflammatory and cardiometabolic risk biomarkers and the fecal microbiome in the Multiethnic Cohort Adiposity Phenotype Study.
    Fu BC; Hullar MAJ; Randolph TW; Franke AA; Monroe KR; Cheng I; Wilkens LR; Shepherd JA; Madeleine MM; Le Marchand L; Lim U; Lampe JW
    Am J Clin Nutr; 2020 Jun; 111(6):1226-1234. PubMed ID: 32055828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
    Skagen K; Trøseid M; Ueland T; Holm S; Abbas A; Gregersen I; Kummen M; Bjerkeli V; Reier-Nilsen F; Russell D; Svardal A; Karlsen TH; Aukrust P; Berge RK; Hov JE; Halvorsen B; Skjelland M
    Atherosclerosis; 2016 Apr; 247():64-9. PubMed ID: 26868510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes: The Cardiovascular Health Study.
    Lemaitre RN; Jensen PN; Wang Z; Fretts AM; McKnight B; Nemet I; Biggs ML; Sotoodehnia N; de Oliveira Otto MC; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
    JAMA Netw Open; 2021 Aug; 4(8):e2122844. PubMed ID: 34448864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral L-carnitine supplementation increases trimethylamine-N-oxide but reduces markers of vascular injury in hemodialysis patients.
    Fukami K; Yamagishi S; Sakai K; Kaida Y; Yokoro M; Ueda S; Wada Y; Takeuchi M; Shimizu M; Yamazaki H; Okuda S
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):289-95. PubMed ID: 25636076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
    Haissman JM; Haugaard AK; Ostrowski SR; Berge RK; Hov JR; Trøseid M; Nielsen SD
    BMC Infect Dis; 2017 Jun; 17(1):445. PubMed ID: 28645263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism.
    Obeid R; Awwad HM; Rabagny Y; Graeber S; Herrmann W; Geisel J
    Am J Clin Nutr; 2016 Mar; 103(3):703-11. PubMed ID: 26864355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TMAO: A small molecule of great expectations.
    Ufnal M; Zadlo A; Ostaszewski R
    Nutrition; 2015; 31(11-12):1317-23. PubMed ID: 26283574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
    Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
    Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
    Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes.
    Croyal M; Saulnier PJ; Aguesse A; Gand E; Ragot S; Roussel R; Halimi JM; Ducrocq G; Cariou B; Montaigne D; Wargny M; Krempf M; Hadjadj S
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32301490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
    Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT
    Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.
    Kuka J; Liepinsh E; Makrecka-Kuka M; Liepins J; Cirule H; Gustina D; Loza E; Zharkova-Malkova O; Grinberga S; Pugovics O; Dambrova M
    Life Sci; 2014 Nov; 117(2):84-92. PubMed ID: 25301199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic investigation of the relationships of trimethylamine
    Gao X; Sun G; Randell E; Tian Y; Zhou H
    Food Funct; 2020 Sep; 11(9):7707-7716. PubMed ID: 32915186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loop diuretics decrease the renal elimination rate and increase the plasma levels of trimethylamine-N-oxide.
    Latkovskis G; Makarova E; Mazule M; Bondare L; Hartmane D; Cirule H; Grinberga S; Erglis A; Liepinsh E; Dambrova M
    Br J Clin Pharmacol; 2018 Nov; 84(11):2634-2644. PubMed ID: 30069897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
    Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
    Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.